Publication list
2023
Pócsi, M.,
Fejes, Z.,
Bene, Z.,
Nagy, A.,
Balogh, I.,
Amaral, M.,
Macek, J.,
Nagy, B.:
Human epididymis protein 4 (HE4) plasma concentration inversely correlates with the improvement of cystic fibrosis lung disease in p.Phe508del-CFTR homozygous cases treated with the CFTR modulator lumacaftor/ivacaftor combination.
J. Cyst. Fibros. 22 (6), 1085-1092, 2023.
Journal metrics:
D1 Pediatrics, Perinatology and Child Health (2022)
D1 Pulmonary and Respiratory Medicine (2022)
2021
Bene, Z.,
Fejes, Z.,
Szántó, G.,
Fenyvesi, F.,
Váradi, J.,
Clarke, L.,
Panyi, G.,
Macek, J.,
Amaral, M.,
Balogh, I.,
Nagy, B.:
Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells.
Front. Pharmacol. 12 1-16, 2021.
Journal metrics:
Q1 Pharmacology
Q1 Pharmacology (medical)
Cunningham, S.,
Piedra, P.,
Martinon-Torres, F.,
Szymanski, H.,
Brackeva, B.,
Dombrecht, E.,
Detalle, L.,
Fleurinck, C.,
RESPIRE Study Group:
Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial.
The Lancet Respiratory Medicine. 9 (1), 21-32, 2021.
2020
Bene, Z.,
Fejes, Z.,
Macek, J.,
Amaral, M.,
Balogh, I.,
Nagy, B.:
Laboratory biomarkers for lung disease severity and progression in cystic fibrosis.
Clin. Chim. Acta. 508 277-286, 2020.
Journal metrics:
Q2 Biochemistry
Q2 Biochemistry (medical)
Q2 Clinical Biochemistry
Q2 Medicine (miscellaneous)
2019
Nagy, B.,
Bene, Z.,
Fejes, Z.,
Heltshe, S.,
Reid, D.,
Ronan, N.,
McCarthy, Y.,
Smith, D.,
Nagy, A.,
Joseloff, E.,
Balla, G.,
Kappelmayer, J.,
Macek, J.,
Bell, S.,
Plant, B.,
Amaral, M.,
Balogh, I.:
Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment.
J. Cyst. Fibros. 18 (2), 271-277, 2019.
Journal metrics:
D1 Pediatrics, Perinatology and Child Health
Q1 Pulmonary and Respiratory Medicine
2018
Balogh, E.,
Nagy, B.,
Gyetvai, Á.,
Bene, Z.,
Hendrik, Z.,
Jeney, V.,
Nagy, P.,
Papp, Á.,
Balla, J.,
Balla, G.,
Kappelmayer, J.,
Nagy, B.:
Impaired Immunosuppressive Effect of Bronchoalveolar Mesenchymal Stem Cells in Hypersensitivity Pneumonitis: preliminary findings.
Cytom. Part B-Clin. Cytom. 94 (2), 363-368, 2018.
Journal metrics:
Q3 Cell Biology
Q2 Histology
Q1 Pathology and Forensic Medicine
2016
Nagy, B.,
Nagy, B.,
Fila, L.,
Clarke, L.,
Gönczy, F.,
Bede, O.,
Nagy, D.,
Újhelyi, R.,
Szabó, Á.,
Anghelyi, A.,
Major, M.,
Bene, Z.,
Fejes, Z.,
Antal-Szalmás, P.,
Bhattoa, H.,
Balla, G.,
Kappelmayer, J.,
Amaral, M.,
Macek, J.,
Balogh, I.:
Human epididymis protein 4 (HE4): a novel serum inflammatory biomarker in cystic fibrosis.
Chest. 150 (3), 661-672, 2016.
Journal metrics:
D1 Cardiology and Cardiovascular Medicine
D1 Critical Care and Intensive Care Medicine
D1 Pulmonary and Respiratory Medicine
2015
Papp, Á.,
Bene, Z.,
Gáspár, I.,
Nagy, B.,
Kádár, L.,
Marialigeti, T.,
Bánfi, A.,
Baktai, G.,
Balla, G.,
Nagy, B.:
Decreased VEGF Level Is Associated with Elevated Ferritin Concentration in Bronchoalveolar Lavage Fluid of Children with Interstitial Lung Diseases.
Respiration. 90 (6), 443-450, 2015.
Journal metrics:
Q1 Pulmonary and Respiratory Medicine
2013
Nagy, B.,
Gáspár, I.,
Papp, Á.,
Bene, Z.,
Nagy, B.,
Vokó, Z.,
Balla, G.:
Efficacy of Methylpredisolone in Children With Severe Community Acquiredpneumonia.
Pediatr. Pulmonol. 48 (2), 168-175, 2013.
Journal metrics:
Q1 Pediatrics, Perinatology and Child Health
Q1 Pulmonary and Respiratory Medicine
2011
Papp, Á.,
Gáspár, I.,
Bene, Z.,
Balázs, G.,
Nagy, B.:
Tévhitek az allergiás náthával kapcsolatban.
Med. Thorac. 64 375-379, 2011.
2010
updated: 2024-04-21, 02:00
